Time to systemic metastases in patients with posterior uveal melanoma

Takami Sato, Akira Babazono, Jerry A. Shields, Carol L. Shields, Patrick De Potter, Michael J. Mastrangelo

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age ≤60, female, diameter ≤10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or survival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment.

Original languageEnglish
Pages (from-to)98-105
Number of pages8
JournalCancer Investigation
Volume15
Issue number2
DOIs
Publication statusPublished - Jan 1 1997

Fingerprint

Neoplasm Metastasis
Age Groups
Proportional Hazards Models
Uveal melanoma
Survival
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Sato, T., Babazono, A., Shields, J. A., Shields, C. L., De Potter, P., & Mastrangelo, M. J. (1997). Time to systemic metastases in patients with posterior uveal melanoma. Cancer Investigation, 15(2), 98-105. https://doi.org/10.3109/07357909709115761

Time to systemic metastases in patients with posterior uveal melanoma. / Sato, Takami; Babazono, Akira; Shields, Jerry A.; Shields, Carol L.; De Potter, Patrick; Mastrangelo, Michael J.

In: Cancer Investigation, Vol. 15, No. 2, 01.01.1997, p. 98-105.

Research output: Contribution to journalArticle

Sato, T, Babazono, A, Shields, JA, Shields, CL, De Potter, P & Mastrangelo, MJ 1997, 'Time to systemic metastases in patients with posterior uveal melanoma', Cancer Investigation, vol. 15, no. 2, pp. 98-105. https://doi.org/10.3109/07357909709115761
Sato, Takami ; Babazono, Akira ; Shields, Jerry A. ; Shields, Carol L. ; De Potter, Patrick ; Mastrangelo, Michael J. / Time to systemic metastases in patients with posterior uveal melanoma. In: Cancer Investigation. 1997 ; Vol. 15, No. 2. pp. 98-105.
@article{bade5c81a6be408fb255537b46f90c58,
title = "Time to systemic metastases in patients with posterior uveal melanoma",
abstract = "A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age ≤60, female, diameter ≤10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or survival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment.",
author = "Takami Sato and Akira Babazono and Shields, {Jerry A.} and Shields, {Carol L.} and {De Potter}, Patrick and Mastrangelo, {Michael J.}",
year = "1997",
month = "1",
day = "1",
doi = "10.3109/07357909709115761",
language = "English",
volume = "15",
pages = "98--105",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Time to systemic metastases in patients with posterior uveal melanoma

AU - Sato, Takami

AU - Babazono, Akira

AU - Shields, Jerry A.

AU - Shields, Carol L.

AU - De Potter, Patrick

AU - Mastrangelo, Michael J.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age ≤60, female, diameter ≤10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or survival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment.

AB - A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age ≤60, female, diameter ≤10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or survival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment.

UR - http://www.scopus.com/inward/record.url?scp=0030959483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030959483&partnerID=8YFLogxK

U2 - 10.3109/07357909709115761

DO - 10.3109/07357909709115761

M3 - Article

C2 - 9095204

AN - SCOPUS:0030959483

VL - 15

SP - 98

EP - 105

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 2

ER -